CSRxP: BIG PHARMA HIKES PRICES ON NEARLY 250 PRESCRIPTION DRUGS IN LATEST ROUND OF MID-YEAR PRICE HIKES
Aug 25, 2026
Brand Name Drug Companies Maintain Business-as-Usual Approach to Price-Gouging… Read More
© 2026 CSRXP- All Rights Reserved
Updates
BIG PHARMA EARNINGS WATCH: ELI LILLY & NOVO NORDISK
Aug 21, 2026
Big Pharma Giants Smash Second Quarter Earnings After Price Hikes Across Their… Read More
BIG PHARMA EARNINGS WATCH: AMGEN, MERCK, GILEAD & PFIZER
Aug 10, 2026
Pharmaceutical Giants Beat Earnings Estimates Following Price Hikes to Start… Read More
BIG PHARMA EARNINGS WATCH: SANOFI, BRISTOL MYERS SQUIBB & ABBVIE
Aug 4, 2026
Brand Name Drug Companies Tout Patent Strategies on Blockbusters That Block… Read More
BIG PHARMA EARNINGS WATCH: ASTRAZENECA & GSK
Jul 29, 2026
Brand Name Drug Companies Book Blockbuster Profits Following Price Hikes… Read More
CSRxP ANALYSIS: BIG PHARMA’S PROFIT MARGINS CLIMB TO 11 TIMES GREATER THAN OTHER SECTORS IN DRUG SUPPLY CHAIN
Jul 27, 2026
Brand Name Drug Companies Banking Ever Higher Profits Fueled by Egregious… Read More
BIG PHARMA EARNINGS WATCH: NOVARTIS & ROCHE
Jul 27, 2026
Big Pharma Giants Continue Topping Wall Street Expectations Following Price… Read More
CSRxP APPLAUDS GROWING BIPARTISAN MOMENTUM TO LOWER PRESCRIPTION DRUG PRICES FOR AMERICAN CONSUMERS BY FOSTERING GREATER COMPETITION
Jul 23, 2026
Both Chambers of Congress and Lawmakers in Both Parties Advance Market-Based… Read More
CSRxP: SENATE HELP COMMITTEE CAN BUILD ON BIPARTISAN MOMENTUM TO BOOST COMPETITION AND LOWER DRUG PRICES
Jul 21, 2026
Lawmakers Have Opportunity to Build On Recent Positive Work to Lower Drug… Read More
CSRxP ENCOURAGES U.S. HOUSE ENERGY & COMMERCE COMMITTEE TO ADVANCE BIPARTISAN SOLUTIONS TO PROMOTE BIOSIMILAR COMPETITION, LOWER DRUG PRICES
Jul 20, 2026
Lawmakers Can Bring More Affordable Alternatives for American Consumers to… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Jul 17, 2026
Johnson & Johnson Tops Profit Expectations, Lifts Outlook Following Price… Read More
CSRxP: SENATE JUDICIARY COMMITTEE MUST REJECT BIG PHARMA’S FALSE RHETORIC ON INNOVATION, HOLD BRAND NAME MANUFACTURERS ACCOUNTABLE FOR PATENT ABUSE
Jul 13, 2026
Big Pharma’s Anti-Competitive Tactics That Extend Monopolies Are… Read More